GNRHR and Graves disease: Anti-GnRHR antibodies appear particularly intriguing, as they have been demonstrated to target the second extracellular loop (ECL2) of the gonadotropin-releasing hormone receptor and act similarly to activating anti-TSHR antibodies in Graves’ disease [69,80].